Who owns TRAVERE THERAPEUTICS INC (TVTX?

Tip: Access positions for across all investors

Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Travere Therapeutics stock

Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Context Capital Management 53M $35B 129596% Dec 2023
 View chart
Wolverine Asset Management 45M $30M 0% Dec 2023
 View chart
D. E. Shaw & Co 41M $27M 0% Dec 2023
 View chart
Highbridge Capital Management 29M $19B 10% Dec 2023
 View chart
Lazard Asset Management 25M $17M 4% Dec 2023
 View chart
Citigroup 20M $13M 0% Dec 2023
 View chart
Aviva 20M $13M -13% Dec 2023
 View chart
Capstone Investment Advisors 19M $13M -17% Dec 2023
 View chart
Braidwell 17M $11M -41% Dec 2023
 View chart
Segantii Capital Management 10M $6.7M 33% Dec 2023
 View chart
Jane Street 3.6M $2.4M 33% Dec 2023
 View chart
Readystate Asset Management 3.0M $2.0M 0% Dec 2023
 View chart
Point72 Asset Management 2.6M $1.7M 0% Dec 2023
 View chart
Lion Point Capital 1.0M $671k 0% Dec 2023
 View chart
Nomura Holdings 482k $4.3M 1% Dec 2023
 View chart
Jpmorgan Chase & Co 125k $81k 0% Dec 2023
 View chart

Who sold out of Travere Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Caas Capital Management Sep 2023 500k $317k